For a decade, Bass, Berry & Sims and Deloitte have brought together leading healthcare industry executives and investors from across the country at our Health Care Investors Conference (HCIC).
Join us virtually at the 10th Annual HCIC as attendees hear from executives and dealmakers on the front lines, covering a range of topics like the impact of COVID-19 on M&A and trends for navigating the new normal, among others. Agenda includes:
|1:00 – 1:10||Welcome Remarks
|1:10 – 1:55||Keynote Presentations:
Potential impacts of November on Health Care and the role of M&A in 2021
Pandemic Threats of Animal-Based Viruses and the Global Pandemic Surveillance System
|1:55 – 2:25||Health Care Transformation and Trends in the Next New Normal – Accelerating the Future of Health
|2:00 – 2:15||Market Dynamics, Emerging Opportunities and Value-Driven M&A Beyond 2020|
|2:55 – 3:00||Closing Remarks
|3:00 – 3:30||Speed Networking Session|
This conference is intended for executive management teams of national health care companies and managing directors and principals of private equity firms. This year’s virtual program will be held Thursday, October 1, from 1:00 – 3:30 PM CST. To register, please contact Lauren Parkhurst.
Not even a pandemic could derail the 10th annual Health Care Investors Conference (HCIC) by Bass, Berry & Sims and Deloitte. Meeting online is not what anyone would prefer, noted Angela Humphreys, Chair of the Health Care Practice Group and Co-Chair of the Health Care Private Equity Team, Bass, Berry & Sims, but for more than 150 attendees, the virtual conference offered many insights from health care executives and investors, as well as the experienced professionals from Bass, Berry & Sims and Deloitte.
Speakers weighed in on how the 2020 U.S. election could impact healthcare policy, the business risk of infectious diseases, the increase demand of data interoperability, and top healthcare sectors for 2021, among other topics. To continue reading click here.